Dr. Gabriella Costabile
Dr. Gabriella Costabile |
Since March 2019 Fondazione Veronesi Fellow at IIT Genova, Italy |
Publications: |
Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles. The Impact of Nylon-3 Copolymer Composition on the Efficiency of siRNA Delivery to Glioblastoma Cells. Lipids and polymers in pharmaceutical technology: lifelong companions Encapsulation of β-sitosterol in plga, peg-pla nanoparticles and its anticancer activity against mcf-7 and mda-mb23 breast cancer cells Physicochemical and in vitro evaluation of drug delivery of an antibacterial synthetic benzophenone in biodegradable PLGA nanoparticles Mannose and Mannose-6-Phosphate Receptor-targeted Drug Delivery Systems and their application in Cancer Therapy Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier. Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections., d'Angelo I, Perfetto B, Costabile G, Ambrosini V, Caputo P, Miro A, d'Emmanuele di Villa Bianca R, Sorrentino R, Donnarumma G, Quaglia F, Ungaro F., Biomacromolecules. 2016; 17 (5):1561-71 Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin., Conte C, Costabile G, d'Angelo I, Pannico M, Musto P, Grassia G, Ialenti A, Tirino P, Miro A, Ungaro F, Quaglia F., J Colloid Interface Sci. 2015; 454:112-20. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology., Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F., Mol Pharm. 2015; 12 (8):2604-17 |